Vulvar dermat may have added an increased risk of missing oses are prevalent inflammatory conditions, frequently associated with itching and burning. The diagnosis is usually clinical but sometimes challenging due to superimposed or associated conditions. This challenge can be harder in postmenopausal women, as the signs and symptoms of vulvovaginal atrophy frequently overlap with those of a dermatosis. Recently, the creation of the “genitourinary syndrome of menopause” may have added an increased risk of missing vulvar diseases.
While these are benign conditions, some (lichen sclerosus and lichen planus) can increase the risk of vulvar cancer, through the pathway of vulvar intraepithelial neoplasia, differentiated type. Failing to recognize this is a missed opportunity to avoid vulvar cancer.
Vulvovaginal symptoms are a frequent cause of gynaecological referral, and dermatologic conditions should always be considered among the differential diagnosis. A systematic evaluation of the symptoms may simplify the diagnostic process.
The authors consider that the classification proposed by the International Society for the Study of Vulvovaginal Diseases (ISSVD), in 2006, and the 2011 terminology are both useful and complimentary tools in daily clinical practice.
In this chapter, the most common vulvar dermatoses encountered in postmenopausal women—lichen simplex chronicus, lichen sclerosus, lichen planus, psoriasis, and atopic and contact dermatitis—are reviewed. An evaluation of the state of the art regarding pathology, classification, and treatment is made.
This is a preview of subscription content, log in to check access.
Conflict of Interest
No conflicts of interest to declare.
Stockdale CK, Boardman L. Diagnosis and treatment of vulvar dermatoses. Obstet Gynecol. 2018;131(2):371–86.CrossRefGoogle Scholar
Ozalp SS, et al. Vulval pruritus: the experience of gynaecologists revealed by biopsy. J Obstet Gynaecol. 2015;35(1):53–6.CrossRefGoogle Scholar
American College of Obstetricians and Gynecologists. Diagnosis and management of vulvar skin disorders. ACOG practice bulletin no. 93. Obstet Gynecol. 2008;111:1243–53.CrossRefGoogle Scholar
Vieira-Baptista P, et al. Deconstructing the genitourinary syndrome of menopause. Int Urogynecol J. 2017;28(5):675–9.CrossRefGoogle Scholar
Lynch PJ, Moyal-Barrocco M, Bogliatto F, Micheletti L, Scurry J. 2006 ISSVD classification of vulvar dermatoses: pathologic subsets and their clinical correlates. J Reprod Med. 2007;52(1):3–9.Google Scholar
Lynch PJ. 2006 International Society for the Study of Vulvovaginal Disease Classification of Vulvar Dermatoses: a synopsis. J Low Genit Tract Dis. 2007;11(1):1–2.CrossRefGoogle Scholar
Lynch PJ, Moyal-Barracco M, Scurry J, Stockdale C. 2011 ISSVD Terminology and Classification of Vulvar Dermatological Disorders: an approach to clinical diagnosis. J Low Genit Tract Dis. 2012;16(4):339–44.CrossRefGoogle Scholar
Lynch PJ. Lichen simplex chronicus (atopic/neurodermatitis) of the anogenital region. Dermatol Ther. 2004;17:8–19.CrossRefGoogle Scholar
Goldstein AT, Marinoff SC, Christopher K, Srodon M. Prevalence of vulvar lichen sclerosus in a general gynecology practice. J Reprod Med. 2005;50(7):477–80.PubMedGoogle Scholar
Leibovitz A, Kaplun VV, Saposhnicov N, Habot B. Vulvovaginal examinations in elderly nursing home women residents. Arch Gerontol Geriatr. 2000;31:1–4.CrossRefGoogle Scholar
Pérez-López FR, Vieira-Baptista P. Lichen sclerosus in women: a review. Climacteric. 2017;20(4):339–47.CrossRefGoogle Scholar
Vieira-Baptista P. Lichen Sclerosus in breast cancer survivor. J Gen Intern Med. 2013;28(3):344.CrossRefGoogle Scholar
Vieira-Baptista P, Lima Silva J, Cavaco-Gomes J, Beires J, Martinez-De-Oliveira J. What differentiates symptomatic from asymptomatic women with lichen sclerosus? Gynecol Obstet Invest. 2015;79:263–8.CrossRefGoogle Scholar
Xavier J, Vieira-Baptista P, Moreira A, Portugal R, Beires J. Vaginal lichen sclerosus: report of two cases. Facts Views Vis Obgyn. 2017;9(3):171–3.PubMedGoogle Scholar
Halonen P, Jakobsson M, Heikinheimo O, Riska A, Gissler M, Pukkala E. Lichen sclerosus and risk of cancer. Int J Cancer. 2017;140:1998–2002.CrossRefGoogle Scholar
Preti M, Scurry J, Marchitelli CE, Micheletti L. Vulvar intraepithelial neoplasia. Best Pract Res Clin Obstet Gynaecol. 2014;28:1051–62.CrossRefGoogle Scholar
Cooper SM, Gao XH, Powell JJ, Wojnarowska F. Does treatment of vulvar lichen sclerosus influence its prognosis? Arch Dermatol. 2004;140:702–6.CrossRefGoogle Scholar
Brodrick B, Belkin ZR, Goldstein AT. Influence of treatments on prognosis for vulvar lichen sclerosus: facts and controversies. Clin Dermatol. 2013;780–6(2013):31.Google Scholar
Drake LA, Dinehart SM, Farmer ER, et al. Guidelines of care for the use of topical glucocorticosteroids. J Am Acad Dermatol. 1996;35:615–9.CrossRefGoogle Scholar
Funaro D, Lovett A, Leroux N, Powell J. A double-blind, randomized prospective study evaluating topical clobetasol propionate 0.05% versus topical tacrolimus 0.1% in patients with vulvar lichen sclerosus. J Am Acad Dermatol. 2014;71:84–91.CrossRefGoogle Scholar
Lee A, Bradford J, Fischer G. Long-term management of adult vulvar lichen sclerosus: a prospective cohort study of 507 women. JAMA Dermatol. 2015;151:1061–7.CrossRefGoogle Scholar
Eshtiaghi P, Sadownik L. Fact or fiction? Adipose-derived stem cells and platelet-rich plasma for the treatment of vulvar lichen sclerosus. J Low Genit Tract Dis. 2018;1:2018.Google Scholar
Micheletti L, Preti M, Bogliatto F, Zanotto-Valentino MC, Ghiringhello B, Massobrio M. Vulval lichen planus in the practice of a vulval clinic. Br J Dermatol. 2000;143(6):1349–50.CrossRefGoogle Scholar
Alaizari N, Al-Maweri S, Al-Shamiri H, Tarakji B, Shugaa-Addin B. Hepatitis C virus infections in oral lichen planus: a systematic review and meta-analysis. Aust Dent J. 2016;61(3):282–7.CrossRefGoogle Scholar
Fruchter R, Melnick L, Pomeranz MK. Lichenoid vulvar disease: a review. Int J Womens Dermatol. 2017;3(1):58–64.CrossRefGoogle Scholar
Cooper SM, Wojnarowska F. Influence of treatment of erosive lichen planus of the vulva on its prognosis. Arch Dermatol. 2006;142:289–94.PubMedGoogle Scholar
Meeuwis KA, de Hullu J, Massuger LF, van de Kerkhof PC, van Rossum MM. Genital psoriasis: a systematic literature review on this hidden skin disease. Acta Derm Venereol. 2011;91:5–11.CrossRefGoogle Scholar
American College of Obstetricians and Gynecologists. Management of menopausal symptoms. ACOG Practice Bulletin Number 141. Obstet Gynecol. 2014;123:202–16.CrossRefGoogle Scholar
Sand FL, Thomsen SF. Skin diseases of the vulva: eczematous diseases and contact urticaria. J Obstet Gynaecol. 2018;38(3):295–300.CrossRefGoogle Scholar
Stockdale CK, Boardman LA. Evaluation and treatment of postmenopausal dyspareunia. J Clin Outcomes Manag. 2011;414–23(2011):18.Google Scholar
North American Menopause Society. Management of symptomatic vulvovaginal atrophy: 2013 position statement of the North American Menopause Society. Menopause. 2013;20:888–902, 2013.CrossRefGoogle Scholar